BiondVax Pharmaceuticals Ltd (NASDAQ:BVXV)
| 3.12 Delayed Data As of Oct 29 |  -0.23 / -6.85%Today’s Change | 2.81 Today|||52-Week Range 62.00 | -66.42% Year-to-Date |
Latest BVXV News | Press Releases
| Why BiondVax Pharmaceuticals Stock Imploded Today Oct 23 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 3.36 |
| Today’s open | 3.60 |
| Day’s range | 3.00 - 3.65 |
| Volume | 1,496,178 |
| Average volume (3 months) | 598,223 |
| Market cap | $39.3M |
Data as of 4:00pm ET, 10/29/2020
Growth & Valuation
| Earnings growth (last year) | -0.51% |
| Earnings growth (this year) | +81.82% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ISRIsoRay Inc | -0.00 | -0.02% |
| ---- | ||
| MTPMidatech Pharma PLC | +0.02 | +1.09% |
| CYANCyanotech Corp | +0.17 | +6.00% |
Data as of 3:59pm ET, 10/29/2020
Financials
| Next reporting date | November 24, 2020 |
| EPS forecast (this quarter) | -$0.01 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$30.6M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Jerusalem, Jerusalem |
Forecasts
